Phase I Trial of LCL161 and Gemcitabine Plus Nab-Paclitaxel in Metastatic Pancreatic Cancer

NCT01934634 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Pancreatic Cancer

Interventions

DRUG: LCL161
DRUG: Gemcitabine
DRUG: nab-Paclitaxel

Sponsor

US Oncology Research

Collaborators

[object Object]
[object Object]